Jump to Main Content

Press Releases

American Society of Hematology Selects 30 Medical Students and Residents for 2016 HONORS Award

(WASHINGTON – July 6, 2016) The American Society of Hematology (ASH) today announced the names of 15 medical students and 15 residents selected to receive the 2016 ASH HONORS (Hematology Opportunities for the Next Generation of Research Scientists) Award.

The ASH HONORS Award aims to support the career development of talented North American medical students and residents interested in hematology. Recipients receive a stipend of $5,000 to conduct either short-term (up to three months) or long-term hematology research projects (between three and 12 months) and $1,000 each year for two years to support their attendance at a program orientation at the ASH annual meeting. Each HONORS participant will have an ASH member research mentor who will assist and oversee the awardee’s work and progress.

“By supporting hematologists-in-training early in their research careers, it is our goal to encourage talented medical students and residents to continue to pursue careers in hematology,” said ASH President Charles S. Abrams, MD, of the University of Pennsylvania. “We look forward to watching their promising careers unfold.”

The 2016 ASH HONORS Award recipients are:

Medical Students:

Recipients Research Topics

Arielle Abovich
University of Alabama Medical Center
Tuscaloosa, AL

IPS derived CD38-targeted CAR T-cell generation in multiple myeloma

Ana Luiza Altaffer
University of Pennsylvania
Philadelphia, PA

Adoptive T-cell therapy for elimination of factor VIII inhibitors

Rahul Bhansali
University of Illinois College of Medicine
Chicago, IL

Uncovering the mechanism of DYRK1A in lymphopoiesis and acute lymphoblastic leukemia

Michelle Chen
Thomas Jefferson University
Philadelphia, PA

Determination of the role of splicing factor 3B Subunit 1 (SF3B1) mutations in MDS pathogenesis

Sean Dougherty
Virginia Commonwealth University Health System
Richmond, VA

Accelerated immunoaging following immune reconstitution in long-term survivors of allogeneic hematopoietic stem cell transplantation

Richard Godby
University of Cincinnati College of Medicine
Cincinnati, OH

Duffy antigen receptor for chemokines expressed on red blood cells: a new player in vascular dysfunction

Naomi Gunawardena
UPMC Medical Education
Pittsburgh, PA

Is mitochondrial aconitase required for erythropoiesis?

Parisa Khalighi
Case Western Reserve University
Cleveland, OH

The role of PAR4 polymorphisms in sickle cell disease

Jerry Lee
Duke University Hospital
Durham, NC

Universal off-the-shelf T-cell therapy for B-cell malignancies

Orly Leiva
Boston University School of Medicine
Boston, MA

The role of lysyl oxidase in facilitating JAK2V617F mutation-induced myelofibrosis

Vivian Liu
Harvard Medical School
Boston, MA

Understanding mechanisms of venetoclax resistance in B-cell malignancies

Ariel Siegel
University of Maryland School of Medicine
Baltimore, MD

Role of RAB5 in erythropoiesis

Ishan Tatake
University of Connecticut
Farmington, CT

Folate receptor expression on CAR T-cells as a mechanism for in vivo imaging and T-cell elimination

Elsa Treffeisen
Thomas Jefferson University
Philadelphia, PA

The in vivo role of NETs in HIT

Christopher Tricarico
Washington University in St. Louis School of Medicine
St. Louis, MO

Determining the effect of ATRA on chromatin structure and transcription in acute promyelocytic leukemia


Recipients Research Topics

Kathryn Bradford, MD
UCLA Medical Center
Los Angeles, CA

Analysis of busulfan pharmacokinetics in patients treated with gene therapy

Joseph Clara, MD
Morsani College of Medicine, University of South Florida
Tampa, FL

Single institution experience in the management of CD30+ lymphoproliferative disorders

Nicole Cruz, MD
New York Presbyterian Hospital Cornell
New York, NY

Optimized assessment of the leukemia stem cell marker CD123 to guide therapy

Kyle Davis, MD
Ohio State University Hospital
Columbus, OH

Hematuria in hemophilia patients found on routine urinalysis

Susan DeWolf, MD
New York Presbyterian Hospital Columbia
New York, NY

A new window into the human alloresponse via high-throughput T-cell receptor sequencing

Harold Elias, MD
Memorial Sloan Kettering
New York, NY

Post-transcriptional regulation of gene expression in hematopoietic stem cells

Karine Gauthier, MD
University of Ottawa
Ottawa, ON

Preventing maternal mortality: VTE prophylaxis with LMWH in the postpartum period, a before and after study

Ashwin Kishtagari, MD
Memorial Sloan Kettering Cancer Center
New York, NY

Clinical outcomes of MDS patients who are medically eligible for allogeneic stem cell transplant

Harry Lesmana, MD
Cincinnati Children's Hospital Medical Center
Cincinnati, OH

Elucidating the roles of Ras-RGL2-Ral pathway in erythropoiesis

Konstantinos Lontos, MD
UPMC Medical Education
Pittsburgh, PA

Semaphorin 4D in multiple myeloma

Luis Malpica Castillo, MD
Jackson Memorial Hospital
Miami, FL

Targeting CD30 expression in adult T-cell leukemia-lymphoma (ATL)

Rushad Patell, MD
Cleveland Clinic Foundation
Cleveland, OH

Identifying predictors for stroke in patients with cancer and atrial fibrillation; a cohort study.

Praful Ravi, MD
Mayo Clinic Rochester
Rochester, MN

Evolving changes in disease biomarkers and risk of progression in smoldering multiple myeloma.

Chris Reilly, MD
University of Pennsylvania
Philadelphia, PA

Clinical outcomes of transjugular intrahepatic portosystemic shunt procedure for MPN-associated portal hypertension

Sarah Rumler, MD
University of Illinois College of Medicine
Peoria, IL

Neurocognitive effect of red blood cell transfusion in pediatric oncology patients with anemia secondary to myelosuppressive chemotherapy

The American Society of Hematology (www.hematology.org) is the world’s largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems by promoting research, clinical care, education, training, and advocacy in hematology. The official journal of ASH is Blood (www.bloodjournal.org), the most cited peer-reviewed publication in the field, which is available weekly in print and online.

Sara Khalaf, American Society of Hematology
[email protected]; 202-552-4925